Do you want to read an article? Please log in or register.
The Smoker's Paradox Revisited: A Patient-Level Pooled Analysis of 18 Randomized Controlled Trials
Therapy and Intervention
Related content
Atrial Fibrillation
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials
Eur Heart J.
Henry TD, Losordo DW, Traverse JH, Schatz RA, Jolicoeur EM, Schaer GL, Clare R, Chiswell K, White CJ, Fortuin FD, Kereiakes DJ, Zeiher AM, Sherman W, Hunt AS, Povsic TJ
doi: 10.1093/eurheartj/ehx764.
RECOMMENDED
Lipid-Lowering Drugs
Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
J Am Coll Cardiol
Wright RS, Ray KK, Raal FJ, Kallend DG, Jaros M, Koenig W, Leiter LA, Landmesser U, Schwartz GG, Friedman A, Wijngaard PLJ, Garcia Conde L, Kastelein JJP, ORION Phase III Investigators.
doi: 10.1016/j.jacc.2020.12.058
Heart, Artery and Coronary DiseasesTherapy and Intervention
Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study
Am Heart J.
Laursen PN, Holmvang L, Lønborg J, Køber L, Høfsten DE, Helqvist S, Clemmensen P, Kelbæk H, Jørgensen E, Lassen JF, Pedersen F, Høi-Hansen T, Therkelsen CJ, Tilsted HH, Jensen LO, Nepper-Christensen L, Sadjadieh G, Engstrøm T
doi: 10.1016/j.ahj.2018.05.018.
Therapy and Intervention
Long-Term Outcomes After Revascularization for Stable Ischemic Heart Disease: An Individual Patient-Level Pooled Analysis of 19 Randomized Coronary Stent Trials
Circ Cardiovasc Interv.
Madhavan MV, Redfors B, Ali ZA, Prasad M, Shahim B, Smits PC, von Birgelen C, Zhang Z, Mehran R, Serruys PW, Maehara A, Leon MB, Kirtane AJ, Stone GW
doi: 10.1161/CIRCINTERVENTIONS.
Further Publications
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of individual patient data from five randomized trials
Am Heart J
Pilgrim T, Rothenbühler M, Siontis GC, Kandzari DE, Iglesias JF, Asami M, Lefèvre T, Piccolo R, Koolen J, Saito S, Slagboom T, Muller O, Waksman R, Windecker S
doi: 10.1016/j.ahj.2021.02.009
Heart, Artery and Coronary DiseasesLipid-Lowering Drugs
Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia
JAMA Cardiol.
Banach M, Duell PB, Gotto AM Jr, Laufs U, Leiter LA, Mancini GBJ, Ray KK, Flaim J, Ye Z, Catapano AL
doi: 10.1001/jamacardio.2020.2314.
RECOMMENDED
Lipid-Lowering Drugs
Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control
Atherosclerosis.
Vallejo-Vaz AJ, Ray KK, Ginsberg HN, Davidson MH, Eckel RH, Lee LV, Bessac L, Pordy R, Letierce A, Cannon CP
doi: 10.1016/
Myocardial InfarctionTherapy and Intervention
Multivessel versus culprit-only PCI in STEMI patients with multivessel disease: meta-analysis of randomized controlled trials
Clin Res Cardiol.
Feistritzer HJ, Jobs A, de Waha-Thiele S, Eitel I, Freund A, Abdel-Wahab M, Desch S, Thiele H
doi: 10.1007/s00392-020-01637-6.
Myocardial Infarction
Hypothermia in patients with acute myocardial infarction: a meta-analysis of randomized trials
Clin Res Cardiol.
Alushi B, Ndrepepa G, Lauten A, Lahmann AL, Bongiovanni D, Kufner S, Xhepa E, Laugwitz KL, Joner M, Landmesser U, Thiele H, Kastrati A, Cassese S
doi: 10.1007/s00392-020-01652-7.